Meta-analysis2024

Effects of rapeseed oil on body composition and glucolipid metabolism in people with obesity and overweight: a systematic review and meta-analysis

Yang JM, Long Y, Ye H, Wu YL, Zhu Q, Zhang JH, Huang H, Zhong YB, Luo Y, Wang MY

European journal of clinical nutrition · 8 citations

How it was studied

Design
Meta-analysis (indexed by PubMed)
Studied in
People
Main outcome
Health markers and function
Intake measured by
Not stated

Who paid for it

Funding
Independent funding
Government
National Natural Science Foundation of China
Government
Natural Science Foundation of Jiangxi Province
Government
Natural Science Foundation of Jiangxi Province (Jiangxi Province Natural Science Foundation)
Government
National Natural Science Foundation of China (National Science Foundation of China)
Grants
National Natural Science Foundation of China (82060420); Natural Science Foundation of Jiangxi Province (20212BAB206004)

Based on 4 listed funder(s).

Publication

Published
2023-09-22 · Eur J Clin Nutr · vol. 78 · issue 1 · pp. 6–18
Publisher
Springer Nature
Cited
10 citations · more than 58% of similar papers · 0.6× the field average
References
65 works
Access
Paywalled
Research areas
Nutritional Studies and Diet · Fatty Acid Research and Health · Obesity, Physical Activity, Diet
Keywords
Overweight, Medicine, Obesity, Internal medicine, Randomized controlled trial, Crossover study, Apolipoprotein B, Endocrinology, Cholesterol, Placebo
MeSH
humans, obesity, apolipoproteins b, body composition, overweight, cholesterol, ldl, rapeseed oil

10 authors

From CN

  • Jia‐ming YangGannan Medical University; First Affiliated Hospital of Gannan Medical University
  • Yi LongGannan Medical University
  • Hua YeGannan Medical University
  • Yanlin WuGannan Medical University
  • Qiang ZhuFirst Affiliated Hospital of Gannan Medical University
  • Jiahong ZhangFirst Affiliated Hospital of Gannan Medical University

Abstract

To investigate the effects of rapeseed oil on body composition, blood glucose and lipid metabolism in people with overweight and obesity compared to other cooking oils. We searched eight databases for randomized controlled studies (including randomized crossover trials). The risk of bias for the included studies was assessed using the Cochrane Risk of Bias 2.0 tool. The Grading of Recommendations Assessment Development and Evaluation (GRADE) criteria were used to evaluate the quality of the outcomes. The methodological quality of the included studies was assessed using the Physiotherapy Evidence Database (PEDro) scale. Sensitivity analysis was used to check the stability of the pooled results. Statistical analysis was carried out using Review Manager 5.3 software. As a result, fifteen randomized controlled studies (including six parallel studies and nine crossover studies) were included in this study. Compared to other edible oils, rapeseed oil significantly reduced low density lipoprotein cholesterol (LDL-C) (MD = -0.14 mmol/L, 95% CI: -0.21, -0.08, I2 = 0%, P 2 = 0%, P = 0.0003), ApoB/ApoA1 (MD = -0.02, 95% CI: -0.04, -0.00, I2 = 0%, P = 0.02) and insulin (MD = -12.45 pmol/L, 95% CI: -19.61, -5.29, I2 = 37%, P = 0.0007) levels, and increased fasting glucose (MD = 0.16 mmol/L, 95% CI: 0.05, 0.27, I2 = 27%, P = 0.003) levels. However, the differences in body weight and body composition between rapeseed oil and control oils were not significant. In a word, rapeseed oil is effective in reducing LDL-C, ApoB and ApoB/ApoA1 levels in people with overweight and obesity, which is helpful in preventing and reducing the risk of atherosclerosis. PROSPERO registration number: CRD42022333436.

Abstract via Europe PMC. Copyright remains with the authors or publisher.

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.